滋养细胞肿瘤患者再妊娠相关问题

摘要/Abstract

摘要：

妊娠滋养细胞肿瘤（GTN）包括侵蚀性葡萄胎、绒毛膜癌、胎盘部位滋养细胞肿瘤和上皮样滋养细胞肿瘤。由于GTN多发生于育龄妇女，治疗的同时保留患者的生育功能显得尤为重要。文章详细阐述了保留生育功能治疗GTN的方法（包括化疗、栓塞治疗、保守性手术、放疗等）及其对生育功能的影响，并对治疗后再妊娠的结局进行了阐述。

关键词: 妊娠滋养细胞肿瘤, 保留生育功能治疗, 再次妊娠

Abstract:

Abstract：Gestational trophoblastic neoplasm includes invasive mole, choriocarcinoma, placental site trophoblastic tumor and epithelial trophoblastic tumor. Fertility sparing therapy for these patients is especially important because these diseases often involve reproductive aged women. This article expounds fertility sparing therapy for GTN including chemotherapy, embolotherapy, conservative surgery, and radiotherapy. The outcome of successor pregnancies after fertility sparing therapy is reviewed as well.

Key words: gestational trophoblastic neoplasms, fertility sparing therapy, successor pregnancies

中图分类号:

R711.74

赵峻，向阳. 滋养细胞肿瘤患者再妊娠相关问题[J]. 中国实用妇科与产科杂志.

参考文献

[1］ Lurain JR. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia［J］. Am J Obstet Gynecol, 2011,204(1):11-18.

[2］ Noal S, Joly F, Leblanc E. Management of gestational trophoblastic disease［J］. Gynecol Obstet Fertil, 2010,38(3): 193-198.

[3］ Feng F, Xiang Y, Wan X, et al. Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia［J］. Ann Oncol, 2011,22(7):1588-1594.

[4］ Tse KY, Chan KK, Tam KF, et al. 20-year experience of managing profuse bleeding in gestational trophoblastic disease［J］.J Reprod Med,2007,52 (5):397-401.

[5］ Estrella JL, Soriano-Estrella AL. Conservative management of uterine rupture in gestational trophoblastic neoplasia: a report of 2 cases［J］. Int J Gynecol Cancer, 2009,19(9):1666-1670.

[6］ Soper. Role of surgery and radiation therapy in the management of gestational trophoblastic disease［J］. Best Pract Res Clin Obstet Gynaecol, 2003,17(6):943-957.

[7］ Soper JT, Spillman M, Sampson JH, et al. High-risk gestational trophoblastic neoplasia with brain metastases: Individualized multidisciplinary therapy in the management of four patients［J］. Gynecol Oncol, 2007,104:691-694.

[8］ Hanna RK, Soper JT. The role of surgery and radiation therapy in the management of gestational trophoblastic disease［J］. Oncologist, 2010,15(6):593-600.

[9］ Chuai Y, Xu X, Wang A. Preservation of fertility in females treated for cancer［J］. Int J Biol Sci, 2012,8(7):1005-1012.

[10］ Rodriguez N, Goldstein DP, Berkowitz RS. Treating gestational trophoblastic disease［J］. Expert Opin Pharmacother, 2010,11(18):3027-3039.

[11］向阳.宋鸿钊滋养细胞肿瘤学［M］.3版.北京:人民卫生出版社,2011:163-168.

[12］ Zhu L, Song H, Yang X, Pregnancy outcome of patients conceiving within one year after chemotherapy for gestational trophoblastic tumor: a clinical report of 22 cases［J］. Chin Med J (Engl), 1998,111(11):1004-1006.

[13］ Leiserowitz GS, Webb MJ. Treatment of placental site trophoblastic tumor with hysterotomy and uterine reconstruction［J］. Obstet Gynecol, 1996,88(4 Pt 2):696-699.

[14］ Usui H, Kaku H, Kihara M, et al. Molecular distinction of consecutive molar pregnancies［J］. Obstet Gynecol, 2011,117(2 Pt 2):492-495.

[15］ Fisher RA, Khatoon R, Paradinas FJ, et al. Repetitive complete hydatidiform mole can be biparental in origin and either male or female［J］. Hum Reprod, 2000, 15(3): 594-598.

[1]	奚玲, 孙玥. 妊娠滋养细胞肿瘤生育力保留策略[J]. 中国实用妇科与产科杂志, 2022, 38(7): 701-704.
[2]	王芬芬, 鲍可纯, 程晓东. 特殊病理类型妊娠滋养细胞肿瘤的治疗[J]. 中国实用妇科与产科杂志, 2022, 38(7): 696-701.
[3]	程红燕, 向阳. 妊娠滋养细胞肿瘤的免疫治疗[J]. 中国实用妇科与产科杂志, 2022, 38(7): 693-696.
[4]	李克敏, 尹如铁. 高危妊娠滋养细胞肿瘤的治疗[J]. 中国实用妇科与产科杂志, 2022, 38(7): 691-693.
[5]	刘晓梅, 李秀琴. 低危妊娠滋养细胞肿瘤的治疗[J]. 中国实用妇科与产科杂志, 2022, 38(7): 687-691.
[6]	彭美莲, 林开武, 翁宗杰, 吴齐斌, 孙蓬明. 妊娠滋养细胞疾病的影像学特征及意义[J]. 中国实用妇科与产科杂志, 2022, 38(7): 680-684.
[7]	吕卫国, 陈丽莉. 重视妊娠滋养细胞肿瘤的规范化治疗[J]. 中国实用妇科与产科杂志, 2022, 38(7): 673-675.
[8]	苏昊, 冯凤芝. 难治性滋养细胞肿瘤的治疗[J]. 中国实用妇科与产科杂志, 2022, 38(5): 511-514.
[9]	王丽娟, 林海雪, 林仲秋. 《2022 NCCN妊娠滋养细胞肿瘤临床实践指南（第1版）》解读[J]. 中国实用妇科与产科杂志, 2022, 38(1): 78-84.
[10]	王丽娟，林海雪，林仲秋. 《2021 NCCN妊娠滋养细胞肿瘤临床实践指南（第2版）》解读[J]. 中国实用妇科与产科杂志, 2021, 37(5): 564-569.
[11]	王丽娟，林海雪. 《2020年RCOG妊娠滋养细胞疾病管理指南》解读[J]. 中国实用妇科与产科杂志, 2021, 37(2): 198-204.
[12]	向阳，蒋芳. 妊娠滋养细胞肿瘤药物治疗研究进展[J]. 中国实用妇科与产科杂志, 2020, 36(1): 25-28.
[13]	杜江悦，吕卫国. 上皮样滋养细胞肿瘤的诊治[J]. 中国实用妇科与产科杂志, 2017, 33(4): 350-353.
[14]	吕卫国. 复发性耐药性妊娠滋养细胞肿瘤的诊治[J]. 中国实用妇科与产科杂志, 2015, 31(3): 220-223.
[15]	赵峻，向阳. 耐药性滋养细胞肿瘤预后评估及随访[J]. 中国实用妇科与产科杂志, 2015, 31(3): 223-226.